IRIS - Res&Arch Institutional Research Information System - Research & Archive

DI FILIPPO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.617
AS - Asia 2.971
EU - Europa 2.811
SA - Sud America 600
AF - Africa 56
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.064
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.529
SG - Singapore 1.374
IT - Italia 557
BR - Brasile 497
IE - Irlanda 484
CN - Cina 476
HK - Hong Kong 438
RU - Federazione Russa 343
VN - Vietnam 321
UA - Ucraina 248
SE - Svezia 239
DE - Germania 229
FI - Finlandia 173
FR - Francia 135
KR - Corea 119
GB - Regno Unito 110
RO - Romania 52
IN - India 40
CZ - Repubblica Ceca 38
NL - Olanda 38
CA - Canada 37
AR - Argentina 36
PL - Polonia 36
MX - Messico 32
JP - Giappone 31
BD - Bangladesh 28
ID - Indonesia 25
TR - Turchia 25
AT - Austria 24
BE - Belgio 23
ZA - Sudafrica 22
EC - Ecuador 19
IQ - Iraq 17
UZ - Uzbekistan 15
ES - Italia 14
CH - Svizzera 12
LT - Lituania 11
VE - Venezuela 10
CO - Colombia 9
GR - Grecia 9
LB - Libano 9
PK - Pakistan 9
PY - Paraguay 9
HR - Croazia 8
CL - Cile 7
MA - Marocco 7
TN - Tunisia 7
JM - Giamaica 5
KE - Kenya 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
KZ - Kazakistan 4
PE - Perù 4
PH - Filippine 4
UY - Uruguay 4
BG - Bulgaria 3
BO - Bolivia 3
IL - Israele 3
IR - Iran 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
JO - Giordania 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GM - Gambi 1
GY - Guiana 1
HU - Ungheria 1
Totale 10.048
Salva come PNG Salva come JPEG
Città #
Singapore 940
Chandler 512
Dublin 484
Hong Kong 437
Perugia 272
Boardman 230
San Mateo 219
Ashburn 202
Santa Clara 163
Altamura 139
Jacksonville 130
Beijing 127
Dong Ket 121
Seoul 119
Moscow 115
Munich 112
Medford 111
Princeton 110
Lawrence 105
Wilmington 93
Los Angeles 87
Andover 86
Ann Arbor 81
Ho Chi Minh City 70
Des Moines 60
Turku 54
New York 52
Piscataway 48
Helsinki 42
Hanoi 41
Redmond 40
São Paulo 40
The Dalles 39
Falls Church 34
Bucharest 33
Tokyo 29
Brno 27
Warsaw 26
Denver 25
Frankfurt am Main 25
Saint Petersburg 25
Boston 22
Brooklyn 22
Dallas 22
Houston 22
Chennai 21
Chicago 21
Orem 21
Brussels 20
Norwalk 19
Nuremberg 19
Amsterdam 18
Atlanta 18
London 18
Redwood City 18
Montreal 17
Woodbridge 17
Johannesburg 16
Phoenix 15
Vienna 15
Columbus 14
Rio de Janeiro 14
Hefei 13
Poplar 13
San Francisco 13
Stockholm 13
Timisoara 12
Ankara 11
Izmir 11
Manchester 11
Biên Hòa 10
Guangzhou 10
Den Haag 9
Falkenstein 9
Quito 9
San Paolo di Civitate 9
Shenzhen 9
Tashkent 9
Belo Horizonte 8
Campinas 8
Haiphong 8
Rome 8
Salvador 8
Shanghai 8
Brasília 7
Ninh Bình 7
Olomouc 7
Querétaro 7
Roubaix 7
Secaucus 7
Tianjin 7
Toronto 7
Zagreb 7
Da Nang 6
Dhaka 6
Maceió 6
Manaus 6
Mexico City 6
Milan 6
Porto Alegre 6
Totale 6.418
Salva come PNG Salva come JPEG
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 197
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 154
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 132
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 130
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 124
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 121
Hippocampal epileptogenesis in autoimmune encephalitis 111
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 111
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 108
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 107
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 106
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 104
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 104
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 103
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 103
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 103
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 101
ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? 100
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 99
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 98
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 98
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 98
Plasticity and repair in the post-ischemic brain 97
Ischemic bilateral hippocampal dysfunction during transient global amnesia. 96
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 95
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 95
Basi neurobiologiche dei deficit cognitivi nella malattia di Parkinson 94
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 94
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 94
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 92
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 92
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 91
Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis 90
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 88
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. 86
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 86
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 86
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 86
Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction 85
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 85
Mitochondria and the link between neuroinflammation and neurodegeneration. 85
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2 85
A pathophysiological link between dystonia, striatal interneurons and neuropeptide Y 83
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 82
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 81
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 80
Direct and indirect pathways of basal ganglia: a critical reappraisal. 78
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 78
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 78
A young patient with type C multiple system atrophy and hereditary hemochromatosis. 77
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 76
La disfunzione sessuale nei pazienti con sclerosi multipla: prevalenza e impatto dei trattamenti sintomatici 76
Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature 76
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis 75
Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. 74
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 74
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. 74
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 73
The endocannabinoid system in Parkinson's disease. 72
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 71
Distinct levels of dopamine denervation differentially alter striatal synapticplasticity and NMDA receptor subunit composition. 71
Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: Implications for early and differential diagnosis 71
Ischemic stroke injury is mediated by aberrant Cdk5 69
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 69
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 68
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 68
Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory. 67
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 67
Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS 67
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: A multicentre retrospective study 66
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 66
Multiple sclerosis and cognition: synaptic failure and network dysfunction 66
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica 66
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain 66
Teaching NeuroImages: Acute tetraparesis: Mind the brain 65
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors 65
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 65
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 65
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 64
Synaptic dysfunction in multiple sclerosis: A red thread from inflammation to network disconnection 64
Sensitization, glutamate, and the link between migraine and fibromyalgia. 63
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. 63
An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases 63
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. 62
Neurofilament light chain as a biomarker in neurological disorders 62
The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI 62
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 61
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. 61
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop) 60
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion 60
Finding a way to preserve mitochondria: New pathogenic pathways in experimental multiple sclerosis 60
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition. 60
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 60
Infliximab monotherapy for neuro-Behçet's disease: a case report 59
Serum neurofilament light chain as a preclinical marker of neurodegeneration 59
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 59
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease. 58
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 57
Neuroscience: Brain's traffic lights. 57
Does cerebrospinal fluid neurofilament light chain correlate with psychiatric symptoms severity in multiple sclerosis? 57
Totale 8.230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.336
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021396 0 0 0 0 0 50 45 30 63 25 50 133
2021/20221.041 13 158 34 46 49 31 13 290 21 82 158 146
2022/20231.742 119 373 23 152 124 188 6 58 627 4 51 17
2023/2024918 38 84 33 61 6 2 164 13 122 32 162 201
2024/20252.227 27 203 82 106 230 175 112 209 390 136 364 193
2025/20262.954 361 368 288 772 705 460 0 0 0 0 0 0
Totale 10.391